Columbus, Ohio - The targeted therapy onalespib has shown effectiveness in preclinical studies of glioblastoma by researchers at The Ohio State University Comprehensive Cancer Center...
Credit: S Cheal et al., Memorial Sloan Kettering Cancer Center, New York, NY RESTON, Va. - Researchers at Memorial Sloan Kettering Cancer Center in New...
The structure of proteins that protect telomeres (shelterin proteins, from "protective shield") are promising targets to combat cancer but to date there has been no...
Lisbon, Portugal: Patients with advanced breast cancer have a better quality of life for longer if the progression of their disease can be delayed, according...
COLUMBUS, Ohio - In a study published in PLOS ONE, researchers describe two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation...
ROCHESTER, Minn. -- Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating...
SAN ANTONIO -- Women with a history of infertility have a 10 percent increased risk of death compared to those without reported infertility struggles, according...
Credit: University of Colorado Cancer Center Two University of Colorado Cancer Center studies were presented this weekend at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics...
Nearly one-third of women with breast cancer went against their doctor's advice and chose not to begin or complete the recommended adjuvant anti-cancer therapy to...
LUGANO, 31 October 2017. ESMO President, Fortunato Ciardiello, has contributed an editorial on the priorities for future cancer research, to The Lancet Oncology (1) with...
Starving a childhood brain tumour of the amino acid glutamine could improve the effect of chemotherapy, according to an early study led by Queen Mary...
This summer, it was announced that Rhode Island became the first state to pass a law explicitly requiring coverage for fertility preservation prior to gonadotoxic...
Credit: Albert Einstein College of Medicine Albert Einstein College of Medicine researchers report that the composition of people's gut bacteria may explain why some of...
(TORONTO, Canada - Nov. 1, 2017) - Breast cancer researchers have mapped early genetic alterations in normal-looking cells at various distances from primary tumours to...
Bottom Line: The investigational PARP inhibitor talazoparib caused regression of patient-derived xenografts (PDXs) of triple-negative breast cancers (TNBC) that had BRCA mutations and also those...
